In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deals in Depth: August 2010

Executive Summary

Disclosed pre-commercial potential deal values in pharma alliances were on the low side in August - topping the list at only $80 million was Biogen Idec's license to Knopp's Phase II ALS candidate. Life Technologies gained more DNA sequencing tools through its $375 million buy of Ion Torrent Systems in a transaction that also includes $350 million in earn-outs. Pharma financing was up 20% from July, while device company fund-raising was down by more than half.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts